These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 1900240

  • 1. Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes.
    Bogdan C, Stenger S, Röllinghoff M, Solbach W.
    Eur J Immunol; 1991 Feb; 21(2):327-33. PubMed ID: 1900240
    [Abstract] [Full Text] [Related]

  • 2. Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-alpha production by macrophages is induced by the synergistic action of interferon (IFN)-gamma and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN-gamma and IL 4.
    Stenger S, Solbach W, Röllinghoff M, Bogdan C.
    Eur J Immunol; 1991 Jul; 21(7):1669-75. PubMed ID: 1905642
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes.
    Bogdan C, Moll H, Solbach W, Röllinghoff M.
    Eur J Immunol; 1990 May; 20(5):1131-5. PubMed ID: 2113475
    [Abstract] [Full Text] [Related]

  • 4. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
    Green SJ, Crawford RM, Hockmeyer JT, Meltzer MS, Nacy CA.
    J Immunol; 1990 Dec 15; 145(12):4290-7. PubMed ID: 2124240
    [Abstract] [Full Text] [Related]

  • 5. Cytokine interactions in experimental cutaneous leishmaniasis.
    Solbach W, Röllinghoff M, Stenger S, Bogdan C.
    Behring Inst Mitt; 1991 Feb 15; (88):230-8. PubMed ID: 1904708
    [Abstract] [Full Text] [Related]

  • 6. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan 15; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 7. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages.
    Stout RD, Bottomly K.
    J Immunol; 1989 Feb 01; 142(3):760-5. PubMed ID: 2464024
    [Abstract] [Full Text] [Related]

  • 8. IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages.
    Hatzigeorgiou DE, He S, Sobel J, Grabstein KH, Hafner A, Ho JL.
    J Immunol; 1993 Oct 01; 151(7):3682-92. PubMed ID: 8397259
    [Abstract] [Full Text] [Related]

  • 9. Phagocytosis enhances murine macrophage activation by interferon-gamma and tumor necrosis factor-alpha.
    Corradin SB, Buchmüller-Rouiller Y, Mauël J.
    Eur J Immunol; 1991 Oct 01; 21(10):2553-8. PubMed ID: 1915557
    [Abstract] [Full Text] [Related]

  • 10. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
    Doherty TM, Coffman RL.
    J Immunol; 1993 Jun 15; 150(12):5476-83. PubMed ID: 8515072
    [Abstract] [Full Text] [Related]

  • 11. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.
    Belosevic M, Davis CE, Meltzer MS, Nacy CA.
    J Immunol; 1988 Aug 01; 141(3):890-6. PubMed ID: 3135315
    [Abstract] [Full Text] [Related]

  • 12. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
    Shankar AH, Morin P, Titus RG.
    Exp Parasitol; 1996 Nov 01; 84(2):136-43. PubMed ID: 8932763
    [Abstract] [Full Text] [Related]

  • 13. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
    Davis CE, Belosevic M, Meltzer MS, Nacy CA.
    J Immunol; 1988 Jul 15; 141(2):627-35. PubMed ID: 3133412
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.
    Liew FY, Li Y, Millott S.
    J Immunol; 1990 Dec 15; 145(12):4306-10. PubMed ID: 2175327
    [Abstract] [Full Text] [Related]

  • 15. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts.
    Heinzel FP, Rerko RM, Hatam F, Locksley RM.
    J Immunol; 1993 May 01; 150(9):3924-31. PubMed ID: 8473741
    [Abstract] [Full Text] [Related]

  • 16. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
    Scott P.
    J Immunol; 1991 Nov 01; 147(9):3149-55. PubMed ID: 1833466
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation.
    Vouldoukis I, Bécherel PA, Riveros-Moreno V, Arock M, da Silva O, Debré P, Mazier D, Mossalayi MD.
    Eur J Immunol; 1997 Apr 01; 27(4):860-5. PubMed ID: 9130636
    [Abstract] [Full Text] [Related]

  • 18. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.
    Liew FY, Millott S, Li Y, Lelchuk R, Chan WL, Ziltener H.
    Eur J Immunol; 1989 Jul 01; 19(7):1227-32. PubMed ID: 2503386
    [Abstract] [Full Text] [Related]

  • 19. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
    Belosevic M, Finbloom DS, Van Der Meide PH, Slayter MV, Nacy CA.
    J Immunol; 1989 Jul 01; 143(1):266-74. PubMed ID: 2499629
    [Abstract] [Full Text] [Related]

  • 20. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ.
    Immunol Lett; 2006 May 15; 105(1):38-47. PubMed ID: 16466810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.